PROGILASE 300 SR contains Progesterone 300 mg Sustained Release, providing progesterone supplementation for selected luteal support and reproductive-health indications. A premium addition to the PCD Pharma Gynae portfolio.
Progesterone supplementation in selected reproductive and hormonal conditions.
Yes, in some patients.
Take strictly as prescribed. If drowsiness or dizziness occurs, avoid driving. Inform the physician about abnormal bleeding, liver problems or other hormone therapy.
Drowsiness, dizziness, headache, breast tenderness, bloating and nausea may occur.
PROGILASE 300 SR: Progesterone acts on progesterone receptors to support endometrial development and progesterone-dependent reproductive processes; the sustained-release form provides prolonged exposure.
